Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Ironwood Pharmaceuticals (IRWD) Leases (2016 - 2025)

Ironwood Pharmaceuticals' Leases history spans 16 years, with the latest figure at $9.3 million for Q4 2025.

  • For Q4 2025, Leases fell 15.31% year-over-year to $9.3 million; the TTM value through Dec 2025 reached $9.3 million, down 15.31%, while the annual FY2025 figure was $9.3 million, 15.31% down from the prior year.
  • Leases for Q4 2025 was $9.3 million at Ironwood Pharmaceuticals, down from $9.8 million in the prior quarter.
  • Across five years, Leases topped out at $16.3 million in Q1 2021 and bottomed at $9.3 million in Q4 2025.
  • The 5-year median for Leases is $13.1 million (2023), against an average of $13.0 million.
  • The largest annual shift saw Leases dropped 6.69% in 2021 before it fell 15.31% in 2025.
  • A 5-year view of Leases shows it stood at $15.4 million in 2021, then fell by 8.64% to $14.0 million in 2022, then dropped by 10.25% to $12.6 million in 2023, then decreased by 12.38% to $11.0 million in 2024, then dropped by 15.31% to $9.3 million in 2025.
  • Per Business Quant, the three most recent readings for IRWD's Leases are $9.3 million (Q4 2025), $9.8 million (Q3 2025), and $10.2 million (Q2 2025).